Business Context and Reporting Period
This Form 8-K Current Report was filed by WiSA Technologies, Inc. (not Datavault AI Inc.) on May 15, 2024. The filing reports the closing of a registered direct offering and a concurrent private placement of warrants. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol WISA.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $2.6 million.
- Securities Issued:
- Common Stock: 785,000 shares sold at an offering price of $3.31 per share.
- Warrants: Warrants exercisable for up to 785,000 shares at an exercise price of $3.18 per share.
- Transaction Costs:
- Placement Agent Fee: 8.0% of gross proceeds.
- Expense Reimbursement: $50,000 paid to Maxim Group LLC.
- Warrant Terms: Immediately exercisable; expire on the fifth anniversary of issuance. Includes a cashless exercise feature and an "alternative cashless exercise" option subject to stockholder approval.
Material Changes and Agreements
The filing details the entry into a Material Definitive Agreement (Securities Purchase Agreement) and a Placement Agency Agreement. Key covenants include:
- Lock-up Period: The Company is restricted from issuing or selling common stock or convertible securities for 30 days following the closing date, unless required to satisfy Nasdaq listing requirements.
- Variable Rate Transaction Restriction: Prohibition on issuing certain securities constituting a Variable Rate Transaction for six months post-closing.
- Registration Rights: The Company must file a registration statement (Form S-1 or similar) for the resale of Warrant Shares by May 30, 2024, and use commercially reasonable efforts to have it effective within 90 days.
- Stockholder Approval: A meeting must be held by September 30, 2024 to approve the "alternative cashless exercise" feature of the warrants.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, revenue outlook, or management commentary regarding future operational performance. The primary focus is the execution of the capital raise. Risks and contingencies are limited to the terms of the agreements, specifically the dilution potential from warrant exercises and the requirement to maintain Nasdaq listing standards which may force future financings.
Investor Verification Checklist
- Verify the exact net proceeds after deducting the 8.0% placement fee and $50,000 expense reimbursement.
- Confirm the filing status of the Form S-1 registration statement for the Warrant Shares by May 30, 2024.
- Monitor the Company's stock price relative to the $3.18 warrant exercise price to assess immediate dilution risk.
- Check for the scheduling of the stockholder meeting required by September 30, 2024, to approve the alternative cashless exercise feature.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for additional covenants not summarized in the 8-K.